Showing 431-440 of 867 results for "".
The Future of Interleukin-based Therapy
https://practicaldermatology.com/topics/practice-management/the-future-of-interleukin-based-therapy/21133/IL inhibitors offer the promise of increased efficacy. Here is a snapshot view of current and investigational agents.Clascoterone: A Novel Topical Anti-androgen for the Treatment of Acne
https://practicaldermatology.com/columns/clinical-focus-1/clascoterone-a-novel-topical-anti-androgen-for-the-treatment-of-acne/23133/For the first time in almost 15 years, a new chemical entity may be coming to the market for the topical treatment of acne vulgaris.Making the Case for Probiotics in Psoriasis Care
https://practicaldermatology.com/topics/psoriasis/making-the-case-for-probiotics-in-psoriasis-care/23702/A literature review reveals much promise, little peril.Thick Melanomas: Assessing Prognosis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/thick-melanomas-assessing-prognosis/23685/New data identifies stratified risk based on the thickness of melanomas thicker than 4mm.Miliary Osteoma Cutis: An Unusual, Sudden-Onset Presentation of a Rare Eruption; Call for Cases
https://practicaldermatology.com/youngmd-connect/resident-resource-center/miliary-osteoma-cutis-an-unusual-sudden-onset-presentationof-a-rare-eruption-call-for-cases/23067/Claim to Fame: When Celebrities Come Forward with Health Conditions, Patients Pay Attention
https://practicaldermatology.com/topics/practice-management/claim-to-fame-when-celebrities-come-forward-with-health-conditions-patients-pay-attention/23751/Lance Bass shared news about his PsA diagnosis, which may improve awareness.Physician Spotlight: Peter van de Kerkhof, MD, PhD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-peter-van-de-kerkhof-md-phd/23431/Therapeutics Focus: Psoriasis
https://practicaldermatology.com/topics/practice-management/therapeutics-focus-psoriasis/21106/New products and pharmacologic developments#GLP-1 Receptor Agonists and the Aesthetic Patient: Considerations for the Dermatologist
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1-receptor-agonists-and-the-aesthetic-patient/48900/The impact of glucagon-like peptide-1 agonists (GLP-1), such as semaglutide, tirzepatide and liraglutide, has transformed the healthcare industry and, in particular, aesthetic dermatology. The most common intended use of these medications, namely diabetes management and weight loss, can lead to a muMelanoma and the Predictive Value of Nevi: Unexpected Findings?
https://practicaldermatology.com/topics/practice-management/melanoma-and-the-predictive-value-of-nevi-unexpected-findings/20936/A new analysis shows that the association between nevi and melanoma is complex.